查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1837116

转染试剂和设备市场（按产品类型、细胞类型、应用和最终用户划分）—2025-2032 年全球预测

Transfection Reagents & Equipment Market by Product Type, Cell Type, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，转染试剂和设备市场将成长至 75.1 亿美元，复合年增长率为 13.15%。

主要市场统计数据
基准年2024年 27.9亿美元
预计2025年 31.5亿美元
预测年份：2032年 75.1亿美元
复合年增长率（%） 13.15%

转染试剂和设备正经历快速的技术和商业性变革，这得益于递送化学、自动化以及基因操作研究范围的不断扩大。过去几年，研究人员和采购团队已将采购重点从成本驱动转向可重复性、扩充性和法规可追溯性。因此，供应商正在大力投资平台的稳健性、检验的方案以及整合的硬体和软体解决方案，以减少不同细胞类型和实验形式的差异。

本引言重点在于报告的主题：创新、营运韧性和最终用户需求。它也强调了产品开发週期如何日益受到分子生物学家、工程师和生物资讯学家之间跨学科合作的影响。它还认识到生物製药公司对支持加速转化工作流程（包括细胞株开发和基因治疗研究）的试剂和设备的日益增长的期望。透过将这些趋势置于更广泛的研究重点和采购惯例实践背景中，引言确立了贯穿报告始终的分析视角，并预示着可操作的洞察将为策略决策提供支援。

变革性转变重新定义了转染工作流程，包括自动化、非病毒递送创新、单细胞方法以及与基因编辑平台的整合

转染生态系统正在经历一场变革性的转变，重塑从实验室到临床的工作流程。首先，转染工作流程的自动化和微型化正在减少人工操作的差异性，并实现更高通量的实验。其次，非病毒递送创新，包括新一代脂质体、聚合物和物理方法，正在扩展可处理的细胞类型和有效载荷的范围，使先前受毒性或低效率限制的应用成为可能。

同时，CRISPR-Cas系统等基因编辑平台的广泛应用使得递送试剂和编辑套件包能够紧密整合，从而形成捆绑解决方案，从而提高编辑效率并减少脱靶效应。单细胞分析和高内涵筛检也影响试剂配方和仪器设计，需要更温和的递送方法和更可重复的条件。此外，监管和品质预期推动了对具有完善文件记录、批次间一致性以及与GMP工作流程相容的试剂和仪器的需求。这些共同的转变迫使供应商和最终用户重新思考其产品蓝图、验证策略和服务模式，以保持竞争力并加速转换效应。

评估 2025 年生效的美国关税对生命科学实验室的供应链、筹资策略和营运弹性的累积影响

2025年关税带来了一系列营运和策略压力，影响了整个转染价值链的采购、供应商关係和成本结构。紧接着，许多实验室和组织重新评估了筹资策略，以缓解短期成本上涨，优先选择製造地分散或能够提供区域库存缓衝的供应商。这些调整通常包括重新协商条款和条件、整合订单以支援价格，以及与经销商密切合作以维持供应的连续性。

从长远来看，关税加速了关键生产回流和供应商裁员的讨论。那些拥有灵活营运能力，能够适应生产重新分配和零件采购变化的公司，在保障实验连续性方面处于有利地位。同时，规模较小的学术和研究机构面临更严峻的预算压力，促使采购团队寻求能够在整个计划中提供更广泛效用的多用途试剂和设备。重要的是，关税上调提升了供应链透明度和供应商风险评估的策略重要性，鼓励各组织投资于供应商资格认证和库存规划，以便在不断变化的贸易条件下维持其开发平臺。

跨产品类型、电池类型、应用程式和最终用户的关键细分洞察揭示了细微的需求驱动因素和采购行为

它揭示了不同产品类型、细胞类型、应用和最终用户的需求模式和营运要求。根据产品类型，市场分为仪器和试剂两类，设备采购越来越受到与自动化系统的兼容性和数据整合的影响，而试剂的评估则基于配方稳定性和跨平台性能。根据细胞类型，市场涵盖细菌、昆虫、哺乳动物和植物细胞，每个类别都专注于转染灵敏度、通量需求以及影响试剂选择和方案开发的验证挑战。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 在 mRNA 疫苗递送和基因编辑应用中采用脂质奈米颗粒製剂
  • 整合自动化高通量转染平台，用于大规模筛检和研究
  • 开发非病毒载体优化策略以提高基因治疗的安全性和递送效率
  • 电转染装置小型化进展，可实现精确的细胞内递送，同时减少细胞损伤
  • 实施人工智慧辅助试剂混合优化可提高转染效率和可重复性。
  • 符合 GMP 标准的转染工作流程的兴起，支持细胞和基因治疗的临床生产
  • 建构基于胜肽的递送系统，用于治疗性货物分子的细胞内标靶运输
  • 扩展双重递送平台，实现 DNA 和 RNA 的共转染，实现复杂的细胞调控
  • 试剂製造中永续製造流程和绿色化学的出现，以减少对环境的影响
  • 采用基于微流体的转染装置进行单细胞分析和精确基因传递

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 转染试剂和设备市场（依产品类型）

  • 装置
  • 试剂

9. 转染试剂和设备市场（依细胞类型）

  • 细菌细胞
  • 昆虫细胞
  • 哺乳动物细胞
  • 植物细胞

第 10 章：转染试剂与设备市场（依应用）

  • 细胞株开发
  • 药物研发
  • 基因治疗研究

第 11 章：转染试剂和设备市场（依最终用户）

  • 学术研究机构
  • 生物製药公司
  • 合约研究组织

第 12 章：转染试剂和设备市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 13 章：转染试剂和设备市场（按类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 14 章。按国家/地区分類的转染试剂和设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Agilent Technologies, Inc.
    • Altogen Biosystems
    • Applied Biological Materials, Inc.
    • Bex Co.,ltd.
    • BioVision Inc.
    • Bio-Rad Laboratories, Inc.
    • Cytiva
    • GeneCopoeia, Inc.
    • Qiagen NV
    • Thermo Fisher Scientific Inc.
Product Code: MRR-031685195779

The Transfection Reagents & Equipment Market is projected to grow by USD 7.51 billion at a CAGR of 13.15% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.79 billion
Estimated Year [2025] USD 3.15 billion
Forecast Year [2032] USD 7.51 billion
CAGR (%) 13.15%

The transfection reagents and equipment landscape is experiencing rapid technological and commercial evolution, driven by converging advances in delivery chemistry, automation, and the expanding scope of gene-modulation research. Over the past several years, researchers and procurement teams have shifted priorities from cost-centric purchasing to an emphasis on reproducibility, scalability, and regulatory traceability. As a result, suppliers are investing heavily in platform robustness, validated protocols, and integrated hardware-software solutions that reduce variability across cell types and experimental formats.

This introduction frames the report's thematic focus on innovation, operational resilience, and end-user needs. It highlights how product development cycles are increasingly informed by cross-disciplinary collaboration between molecular biologists, engineers, and bioinformaticians. In addition, it acknowledges the heightened expectations from biopharmaceutical companies for reagents and instruments that support accelerated translational workflows, including cell line development and gene therapy research. By situating these trends within the broader context of research priorities and procurement practices, the introduction establishes the analytic lens used throughout the report and sets expectations for actionable insights that support strategic decision-making.

Transformative shifts redefining transfection workflows including automation, non-viral delivery innovations, single-cell approaches, and convergence with gene editing platforms

The transfection ecosystem is undergoing transformative shifts that are reshaping workflows from bench to clinic. First, automation and miniaturization of transfection workflows have reduced manual variability and enabled higher-throughput experimentation, which supports more rapid iterative cycles in protocol optimization. Second, non-viral delivery innovations, including next-generation lipids, polymers, and physical methods, are broadening the range of tractable cell types and payloads, enabling applications that were previously constrained by toxicity or low efficiency.

Concurrently, the widespread adoption of gene editing platforms such as CRISPR-Cas systems has created tighter integration between delivery reagents and editing toolkits, leading to bundled solutions that improve editing efficiency and reduce off-target effects. Single-cell analysis and high-content screening are also influencing reagent formulation and instrument design, requiring gentler delivery approaches and highly reproducible conditions. Moreover, regulatory and quality expectations are driving demand for reagents and equipment with robust documentation, lot-to-lot consistency, and compatibility with GMP workflows. Together, these shifts compel suppliers and end users to rethink product road maps, validation strategies, and service models to remain competitive and to accelerate translational impact.

Cumulative impact assessment of United States tariffs introduced in 2025 on supply chains, procurement strategies, and operational resilience across life science labs

The imposition of tariffs in 2025 introduced a set of operational and strategic pressures that have affected procurement, supplier relationships, and cost structures across the transfection value chain. In the immediate aftermath, many laboratories and organizations revisited sourcing strategies to mitigate near-term cost increases, prioritizing suppliers with diversified manufacturing footprints or those able to offer localized inventory buffers. These adjustments often involved renegotiating terms, consolidating orders to preserve pricing, and working more closely with distributors to maintain continuity of supply.

Over a longer horizon, tariffs have accelerated conversations about onshoring critical production and increasing supplier redundancy. Firms with the operational agility to reallocate production or to shift component sourcing have been better positioned to protect experimental continuity. At the same time, smaller academic and research institutions have faced more acute budgetary pressure, prompting procurement teams to seek multi-use reagents and instrumentation that deliver broader utility across projects. Importantly, tariffs have magnified the strategic importance of supply chain transparency and supplier risk assessment, encouraging organizations to invest in vendor qualification and inventory planning to sustain R&D pipelines under evolving trade conditions.

Key segmentation insights across product types, cell types, applications, and end users revealing nuanced demand drivers and procurement behaviors

Segmentation-driven insights reveal differentiated demand patterns and operational requirements across product types, cell types, applications, and end users. Based on Product Type, the market is studied across Equipment and Reagents, with equipment purchases increasingly influenced by compatibility with automation systems and data integration, while reagents are evaluated for formulation stability and cross-platform performance. Based on Cell Type, the market is studied across Bacterial Cells, Insect Cells, Mammalian Cells, and Plant Cells, and each category exhibits distinct transfection sensitivities, throughput needs, and validation challenges that influence reagent selection and protocol development.

Based on Application, the market is studied across Cell Line Development, Drug Discovery, and Gene Therapy Research, with cell line development demanding reproducibility and scale-up pathways, drug discovery emphasizing throughput and assay compatibility, and gene therapy research prioritizing delivery efficiency and regulatory-grade documentation. Based on End User, the market is studied across Academic And Research Institutes, Biopharmaceutical Companies, and Contract Research Organizations, where academic labs often prioritize flexibility and cost-effectiveness, biopharma focuses on qualification and portability to clinical pipelines, and CROs require broad reagent and equipment portfolios to service diverse client needs. Collectively, these segmentation perspectives underscore the importance of tailored value propositions, validated workflows, and service models that address the specific technical and commercial drivers inherent to each category.

Regional dynamics and competitive positioning across the Americas, Europe Middle East & Africa, and Asia-Pacific informing market entry and partnership strategies

Regional dynamics are shaping competitive positioning and go-to-market strategies across major geographies. In the Americas, investment in biopharmaceutical R&D, coupled with a strong presence of contract research organizations and advanced academic centers, drives demand for high-performance reagents and integrated instruments that support translational pipelines. Market participants in this region often prioritize regulatory alignment, vendor transparency, and partnership models that can accelerate clinical translation.

Europe, Middle East & Africa presents a heterogeneous landscape where regulatory frameworks and funding models vary widely, creating both opportunities and complexity. In these markets, suppliers benefit from localized validation data and collaborative partnerships with regional research consortia. Europe in particular emphasizes reproducibility and quality management systems, while several Middle Eastern and African centers are investing in capacity building and infrastructure modernization. Asia-Pacific is characterized by rapid expansion in life science R&D capability, government-led initiatives to support biotechnology, and a growing manufacturing base. Suppliers operating in Asia-Pacific are increasingly localizing production and offering scalable solutions that cater to a broad range of end users, from emerging academic centers to large domestic biopharma firms. Understanding these regional nuances is essential for prioritizing market entry tactics, distribution strategies, and localized service offerings.

Strategic profiles and capability analysis of leading companies shaping transfection reagents and equipment through R&D, partnerships, and platform expansion

Leading companies in the space are differentiating through a combination of R&D investment, strategic partnerships, and expanding platform capabilities. Some firms are concentrating on reagent chemistry optimization to enhance delivery efficiency and reduce cytotoxicity across challenging cell types, while others are integrating hardware, software, and consumables to deliver turnkey solutions that lower the barrier to adoption. Collaborations between reagent developers and instrument manufacturers are becoming more common, as are partnerships with academic labs and contract research organizations to validate workflows across diverse applications.

Corporate strategies also reflect an emphasis on regulatory readiness and quality systems that support translational use cases. Companies that proactively generate comprehensive validation data and provide robust technical support are establishing credibility with biopharmaceutical customers and CROs. Additionally, several firms are exploring modular business models, combining direct sales with channel partnerships and subscription services for consumables and software. These approaches enhance customer lifetime value and create recurring revenue streams while enabling more predictable supply and service delivery for critical R&D activities.

Actionable recommendations for industry leaders to accelerate adoption, optimize supply chains, and capture value across diverse transfection market segments

Industry leaders should adopt a set of pragmatic actions to accelerate adoption, strengthen supply chains, and capture strategic value across segments. First, invest in creating validated, cross-platform protocols and comprehensive application notes that demonstrate performance across the primary cell types and use cases. This evidence base reduces adoption friction and supports procurement decisions across academic, biopharma, and CRO customers. Second, diversify manufacturing and logistics footprints to mitigate trade and tariff risks while ensuring continuity of supply for critical reagents and instrument components.

Third, pursue strategic alliances with technology partners and end users to co-develop solutions tailored to high-value applications such as gene therapy and complex cell line development. Fourth, enhance commercial models by combining equipment sales with consumable subscriptions and managed services that provide predictable revenue and deeper customer engagement. Finally, strengthen technical service and training offerings to support reproducibility and to facilitate rapid scale-up from discovery to translational stages. Together, these actions will help suppliers align product development and go-to-market execution with evolving customer expectations and regulatory requirements.

Research methodology detailing data sources, stakeholder interviews, primary and secondary research integration, and analytical frameworks ensuring rigor

The research methodology underpinning this analysis integrates primary interviews, secondary data synthesis, and cross-validated expert review to ensure analytical rigor and relevance. Primary research included structured interviews with laboratory directors, procurement managers, R&D scientists, and commercial leaders across a representative set of academic institutions, biopharmaceutical companies, and contract research organizations. These conversations provided direct insight into procurement drivers, performance pain points, and validation priorities.

Secondary research involved a systematic review of peer-reviewed literature, regulatory guidance, patent filings, and technical white papers to contextualize technological trends and to verify product claims. Data triangulation was applied to reconcile divergent inputs and to surface consistent patterns across geographies and end-user types. Analytical frameworks used in the study include value chain mapping, supplier capability assessment, and scenario-based sensitivity analysis to explore the impacts of supply disruption and regulatory change. Throughout, subject matter experts provided iterative review to refine interpretations and to ensure that findings are actionable for decision-makers.

Conclusion synthesizing strategic implications, risk considerations, and priority actions for stakeholders navigating the transfection ecosystem

In conclusion, the transfection reagents and equipment ecosystem is advancing at the intersection of innovation, regulatory expectation, and shifting procurement behaviors. Technological progress in delivery chemistries, automation, and integration with gene editing platforms is expanding the range of tractable applications while raising the bar for reproducibility and quality assurance. At the same time, trade dynamics and evolving regional capabilities are reshaping supply chain strategies and commercial approaches.

Stakeholders should prioritize resilience, validated performance, and customer-centric service models to capture emerging opportunities. For product developers, the imperative is to align R&D investment with the specific needs of diverse cell types and application areas. For end users, building robust vendor qualification and inventory management practices will protect continuity of research. As the field evolves, coordinated partnerships among suppliers, customers, and regulatory bodies will be critical to translate technological potential into clinical and commercial outcomes. The synthesis offered here provides a strategic foundation for informed decision-making and targeted action in this dynamic sector.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of lipid nanoparticle formulations for mRNA vaccine delivery and gene editing applications
  • 5.2. Integration of automated high-throughput transfection platforms for large scale screening and research
  • 5.3. Development of nonviral vector optimization strategies to enhance safety and delivery efficiency in gene therapy
  • 5.4. Advances in electrotransfection device miniaturization for precise intracellular delivery with reduced cell damage
  • 5.5. Implementation of AI driven reagent formulation optimization to improve transfection efficiency and reproducibility
  • 5.6. Rise of GMP compliant transfection workflows to support clinical manufacturing of cell and gene therapies
  • 5.7. Engineering of peptide based delivery systems for targeted intracellular transport of therapeutic cargo molecules
  • 5.8. Expansion of dual delivery platforms enabling simultaneous transfection of DNA and RNA for complex cell modulation
  • 5.9. Emergence of sustainable manufacturing processes and green chemistry in reagent production to reduce environmental impact
  • 5.10. Adoption of microfluidic based transfection devices for single cell analysis and high precision gene delivery

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Transfection Reagents & Equipment Market, by Product Type

  • 8.1. Equipment
  • 8.2. Reagents

9. Transfection Reagents & Equipment Market, by Cell Type

  • 9.1. Bacterial Cells
  • 9.2. Insect Cells
  • 9.3. Mammalian Cells
  • 9.4. Plant Cells

10. Transfection Reagents & Equipment Market, by Application

  • 10.1. Cell Line Development
  • 10.2. Drug Discovery
  • 10.3. Gene Therapy Research

11. Transfection Reagents & Equipment Market, by End User

  • 11.1. Academic And Research Institutes
  • 11.2. Biopharmaceutical Companies
  • 11.3. Contract Research Organizations

12. Transfection Reagents & Equipment Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Transfection Reagents & Equipment Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Transfection Reagents & Equipment Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Agilent Technologies, Inc.
    • 15.3.2. Altogen Biosystems
    • 15.3.3. Applied Biological Materials, Inc.
    • 15.3.4. Bex Co.,ltd.
    • 15.3.5. BioVision Inc.
    • 15.3.6. Bio-Rad Laboratories, Inc.
    • 15.3.7. Cytiva
    • 15.3.8. GeneCopoeia, Inc.
    • 15.3.9. Qiagen N.V.
    • 15.3.10. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. TRANSFECTION REAGENTS & EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. TRANSFECTION REAGENTS & EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. TRANSFECTION REAGENTS & EQUIPMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BACTERIAL CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BACTERIAL CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BACTERIAL CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BACTERIAL CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BACTERIAL CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BACTERIAL CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY INSECT CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY INSECT CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY INSECT CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY INSECT CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY INSECT CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY INSECT CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MAMMALIAN CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MAMMALIAN CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MAMMALIAN CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY MAMMALIAN CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PLANT CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PLANT CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PLANT CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PLANT CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PLANT CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PLANT CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL LINE DEVELOPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GENE THERAPY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GENE THERAPY RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GENE THERAPY RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GENE THERAPY RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GENE THERAPY RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GENE THERAPY RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 88. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 89. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 90. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 91. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 92. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 93. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 94. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 95. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 96. AMERICAS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 100. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 102. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 104. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 106. NORTH AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 110. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 112. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 114. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 116. LATIN AMERICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 127. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 130. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 131. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 132. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 133. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 134. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 135. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 136. EUROPE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 144. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. MIDDLE EAST TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 147. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 151. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 153. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 154. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 155. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 156. AFRICA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 177. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. ASEAN TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 179. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 187. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. GCC TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPEAN UNION TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. BRICS TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 217. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. G7 TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. NATO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 237. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. UNITED STATES TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. CANADA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 253. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. MEXICO TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 261. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. BRAZIL TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. UNITED KINGDOM TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 271. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. GERMANY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 284. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 285. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. FRANCE TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 293. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 294. RUSSIA TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 295. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY CELL TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. ITALY TRANSFECTION REAGENTS & EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 300. ITALY TRANSFECTIO